SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-23-032174
Filing Date
2023-11-15
Accepted
2023-11-15 16:15:00
Documents
2
Period of Report
2023-11-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1349
2 atos20231115b_sec16.htm EX-24 7125
  Complete submission text file 0001437749-23-032174.txt   9910
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Issuer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VANTAGE CONSULTING GROUP, INC. 3500 PACIFIC AVENUE VIRGINIA BEACH VA 23451
Business Address
Finn Jonathan (Reporting) CIK: 0001981595 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35610 | Film No.: 231410749